Dr. Ronald Ackerman, MD
Claim this profileComprehensive Clinical Trials, LLC
Studies Birth Control
Studies Osteoporosis
2 reported clinical trials
2 drugs studied
Affiliated Hospitals
More about Ronald Ackerman, MD
Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Ronald Ackerman, MD has experience with
- NOMAC-E2 COC
- Drospirenone
Breakdown of trials Ronald Ackerman, MD has run
Osteoporosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ronald Ackerman, MD specialize in?
Ronald Ackerman, MD focuses on Birth Control and Osteoporosis. In particular, much of their work with Birth Control has involved treating patients, or patients who are undergoing treatment.
Is Ronald Ackerman, MD currently recruiting for clinical trials?
No, Ronald Ackerman, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Ronald Ackerman, MD has studied deeply?
Yes, Ronald Ackerman, MD has studied treatments such as NOMAC-E2 COC, Drospirenone.
What is the best way to schedule an appointment with Ronald Ackerman, MD?
Apply for one of the trials that Ronald Ackerman, MD is conducting.
What is the office address of Ronald Ackerman, MD?
The office of Ronald Ackerman, MD is located at: Comprehensive Clinical Trials, LLC, West Palm Beach, Florida 33409 United States. This is the address for their practice at the Comprehensive Clinical Trials, LLC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.